权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

P450 Allosterism and Drug Interactions

P450 变构和药物相互作用

基本信息

批准号：
7559323
负责人：
WILLIAM M ATKINS
金额：
$ 23.71万
依托单位：
UNIVERSITY OF WASHINGTON
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-08-01 至 2013-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7559323
关键词：
Active Sites Allosteric Regulation Allosteric Site Antiepileptic Agents Behavior Binding Binding Sites Biological Models CYP17A1 gene CYP2C9 gene CYP2E1 gene CYP3A4 gene Carbamazepine Chemicals Clinical Research Collaborations Complex Computer Simulation Consumption Coupling Cytochrome P450 Cytochromes Data Dose Drug Interactions Electron Transport Exhibits Experimental Designs Fluorescence Fluorescence Spectroscopy Fluorescent Probes Goals Grant Heme Human Hydration status In Vitro Lead Ligands Link Maps Mass Spectrum Analysis Measures Metabolic Metabolic Activation Metabolism Methods Midazolam Modeling Molecular Molecular Conformation NADP Object Attachment Oral Oral Administration Oxidoreductase Oxygen P-Glycoprotein P-Glycoproteins Peripheral Personal Satisfaction Pharmaceutical Preparations Property Protein Isoforms Proteins Protons Radioisotope Dilution Technique Rate Reaction Regulation Relative (related person)Relaxation Reporter Reporting Site Source Structure Sulfonic Acids Surface Testosterone Time base clinically relevant comparative cost crosslink drug metabolism improved in vivo inhibitor/antagonist molecular dynamics nile red novel oxidation predictive modeling prevent programs protein protein interaction small molecule tertiary amine

项目摘要

Cytochrome P450's (CYPs) are a major source of metabolic drug interactions. The allosteric behavior of CYPs, including the major drug metabolizing isoform CYP3A4, continues to confound in vitro - In vivo correlations and the prediction of drug interactions based on in vitro data. The molecular mechanisms that confer allosteric behavior are incompletely understood, and improved mechanistic models are likely to improve predictive drug metabolism. Moreover, although allosteric behavior in vitro is well known and widely observed, examples of in vivo allosterism are limited. Among the multiple mechanisms that contribute, occupancy by small molecule drugs at a peripheral effector site of CYP3A4, and conformational changes induced by the electron transfer partner Cytochrome bs (Cyt bs), are likely to converge on a set of common effects, wherein the active site is more efficiently desolvated or 'well-packed' through protein-protein interactions or multiple drug binding. In turn this, hypothetically, leads to more efficient coupling of NADPH consumption and O2 reduction, concomitant with drug oxidation, with decreased 'uncoupling' to form reduced oxygen species. This proposal aims to: 1) increase our understanding of allosteric CYP mechanisms with model probe drugs, and 2) to complete a comparative, and mechanistic, analysis of CYP-Cyt b5 interactions. The fluorescent probes Nile Red and TNS provide a comparison of the active site hydration and steric constraints of CYP3A4 when the peripheral allosteric site is occupied or empty. Mass spectrometry and computational models provide methods to map binding interactions in Cyt b5-CYP complexes and the resulting conformational changes linked to effector functions of Cyt bs. Each of these approaches will be combined with functional studies to characterize reaction intermediates that determine the efficiency of the flux through the catalytic cycle. A major goal of these studies is to develop their translational utility in conceptually analogous studies with P-glycoprotein in Project 4 of this Program. In addition, the importance of in vivo allosteric effects remains speculative, and the final aim, aim 3, of this proposal will utilize a novel in vivo, human, clinical study to explore heterotropic effects between the antiepileptic drug carbamazapine and the antianxiety drug midazolam. This study not only seeks to establish definitive proof-of-principle for in vivo allosteric effects in human CYPs, but also to provide a platform experimental design to be exploited in other in vivo studies.

细胞色素P450's （CYPs）是代谢药物相互作用的主要来源。的变构行为